** Analysts at Morgan Stanley say Australia's Sonic
Healthcare SHL.AX remains at the top of the brokerage's
preferred list for the country's domestic health services sector
** Says SHL offers the "most palatable" valuation relative
to other large-cap Australian healthcare stocks
** Adds, SHL is performing comparatively better in terms of
earnings drivers as well as revenues
** SHL's strong dividend yield and balance sheet gives it
the upper hand against its peers - MS
** Shares of SHL dropped as much as 0.8% to A$29.510
** SHL down 1.5% this year, as of last close, vs a 1.6%
decrease in benchmark S&P/ASX 200 index .AXJO
(Reporting by Roushni Nair in Bengaluru)
((Roushni.Nair@thomsonreuters.com;))